![PDF) Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma PDF) Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma](https://i1.rgstatic.net/publication/349353755_Examining_the_Relationship_between_Circulating_CD4-_CD8-_Double-Negative_T_Cells_and_Outcomes_of_Immuno-Checkpoint_Inhibitor_Therapy-Looking_for_Biomarkers_and_Therapeutic_Targets_in_Metastatic_Melano/links/604aee4645851543166f3120/largepreview.png)
PDF) Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma
![Cells | Free Full-Text | Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma Cells | Free Full-Text | Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma](https://www.mdpi.com/cells/cells-10-00406/article_deploy/html/images/cells-10-00406-g002.png)
Cells | Free Full-Text | Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma
![Cells | Free Full-Text | Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma Cells | Free Full-Text | Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma](https://www.mdpi.com/cells/cells-10-00406/article_deploy/html/images/cells-10-00406-g001.png)